A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice.
Biochem Biophys Res Commun
; 450(1): 532-7, 2014 Jul 18.
Article
in En
| MEDLINE
| ID: mdl-24924635
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antigens, Differentiation, B-Lymphocyte
/
Antigens, CD
/
Mammary Neoplasms, Animal
/
Mucin-1
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2014
Document type:
Article
Country of publication: